CareDx Announces Completion of Naveris Acquisition; Files 8-K/A

What Happened
CareDx, Inc. announced that it completed the acquisition of Naveris, Inc. (a Delaware corporation) and has amended its prior Form 8-K to provide the historical financial statements of Naveris and related pro forma financial information. The company originally reported the closing in a Form 8-K filed July 7, 2026, and filed this Amendment No. 1 (Form 8-K/A) on September 16, 2026 to comply with SEC requirements under Article 11 of Regulation S‑X.

Key Details

• CareDx disclosed the acquisition of Naveris in an original Form 8-K filed July 7, 2026; the earliest event date listed is June 30, 2026.
• The 8-K/A (Amendment No. 1) filed September 16, 2026 adds Naveris’ historical financial statements and related pro forma financial information.
• The amendment was made to comply with SEC rules and regulations under the Securities Exchange Act of 1934 and the Securities Act of 1933 (Article 11, Reg S‑X).
• Target: Naveris, Inc., a Delaware corporation.

Why It Matters
Filing the historical and pro forma financials gives investors the documentation needed to evaluate how the Naveris acquisition could affect CareDx’s financial results and future reporting. Investors should review the newly filed financial statements and pro forma disclosures in the 8-K/A to assess the acquisition’s impact on revenue, expenses, and balance sheet presentation.